Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artekin for Uncomplicated Plasmodium Falciparum Malaria in Peru
NCT00373607Phase 3Completed
- Sponsor
- Institute of Tropical Medicine Antwerp
- Start
- Jul 2003
- Primary completion
- Jul 2005
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
01
Overview
Phase 3, randomised trial of dihydroartemisinin + piperaquine in malaria (2 arms), sponsored by Institute of Tropical Medicine Antwerp. Primary endpoint: Adequate Clinical and Parasitological Response at Day 63. Started Jul 2003; status: completed.
02
Drugs
dihydroartemisinin + piperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00373607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00373607.